
How to determine whether an ingredient is a novel food in the EU, using the 15 May 1997 cut-off and the Novel Food Catalogue.

Mandatory labelling particulars for food supplements under Directive 2002/46/EC and Regulation 1169/2011, explained step by step.

Which health claims are allowed on food supplements in the EU, how on-hold botanical claims work, and how to stay compliant.

How EU law classifies pet supplements: complementary feed, feed additives or veterinary medicines, and what each route requires.

How to notify or license a food supplement in Greece (EOF) and Cyprus: routes, timelines and documents. Regulatory guidance from PQRA.

The three ISO standards that matter most in life sciences — and what the 2026 ISO 9001 revision means for companies certified today.

Training is a legal obligation under EU GMP and GDP. What the rules require and how to build a training system that survives inspection.

Approval is only the start. How tenders, interchangeability policy and payer evidence decide whether a biosimilar actually gains share.

The EMA no longer expects comparative efficacy studies for well-characterised biosimilars. What the tailored clinical approach means for developers.

New EU pharmacovigilance rules apply from February 2026. Here is what changes for reporting, signal management and inspection readiness.